Followers | 130 |
Posts | 18112 |
Boards Moderated | 0 |
Alias Born | 01/16/2007 |
Sunday, December 23, 2018 8:42:31 PM
HHSE S-1 REGISTRATION
* Direct Stock Purchase (Accredited Investor Buy Directly From HHSE)
* Cash Infusion (Unlike Market Buys, Monies Go Directly To HHSE Coffers)
* 150% of the VWAP of the HHSE shares
* Significant Premium "ABOVE" Market
* $.045 - $.10
* Accretion, NOT Dilution
* Acts as Floor To Stock Price
* Potential $4,500,000
* Money is Deposited in Company Treasury Available For Corporate Investment
4). S-1 REGISTRATION - HHSE has been in discussions with three significant parties that have expressed support of buying HHSE shares under a S-1 Shelf Registration (simultaneous with the Form 10, or almost immediately thereafter). As presently envisioned, the S-1 would be launched in January with a total potential sale of up to 90-mm HHSE shares made available, with a base price anticipated in the $.045 range, and going all the way up to $.10 for the final traunch of shares. HHSE anticipates raising about $4.5-mm in direct operating capital - while only diluting the total A/S by 10% or less. These direct funds will provide marketing support for MyFlix - as well as cash-flow flexibility for assisting with the development of the tent-pole Major Films and other ongoing operations. The anticipated buyers of the S-1 offering are long-term, strategic partners, and are not expected to sell any of their shares in the first year or two. The structure of the S-1 incentivizes earlier subscribers, as the price per share increases as the inventory of S-1 shares is diminished. The base price of the first traunch of S-1 shares is being established to be at a level estimated to start at 150% of the VWAP of the HHSE shares - which means that these new shareholders are buying equity at a significant premium "above" market. The S-1 Registration will be filed shortly after the Form 10, as the company will await any initial feedback and comments to the registration statement.
http://hannoverhousemovies.blogspot.com/2018/11/hhse-myflix-outline-of-key-events.html
HHSE
Recent HHSE News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 07:17:02 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM